Rheumatoid arthritis is a systemic, chronic, and autoimmune disease that can involve joints and many organs. There is a decrease in rheumatoid arthritis activity in pregnancy and the recovery level increases as pregnancy progresses. Among women with rheumatoid arthritis, pregnancy usually ends successfully. In the first 3-12 months after birth, the women’s disease activity increases. Pre-pregnancy rheumatoid arthritis management includes stabilization of the disease process, reduction of drugs to reduce fetal risks, and avoiding the use of teratogenic drugs. If the woman with rheumatoid arthritis is pregnant while taking antirheumatic medicines, a fetal anomaly scan is done. The type of delivery is decided after a multidisciplinary evaluation because it may be difficult to give a position pregnant woman during labor due to joint involvement. Pre-pregnancy drug treatment can be used due to the increase in rheumatoid arthritis activity in the postpartum period. For this reason women used drugs passing into mother’s milk should not breastfeed their babies. In the postpartum period, care and feeding of the baby can be difficult due to the joint problems, deformities, limitations and pain caused by the disease. In this review; disease management during preconceptional, perinatal and postnatal period were addressed in women with rheumatoid arthritis.